These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 6110461
21. The effect of indomethacin on anaphylactic contraction and histamine release in guinea-pig lung parenchymal strips. Creese BR, Temple DM. Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):265-76. PubMed ID: 2428325 [Abstract] [Full Text] [Related]
22. Stimulation of the antigen-induced contraction of guinea-pig trachea and immunological release of histamine and SRS-A from sensitized guinea-pig lung by (2-isopropyl-3-indolyl)-3 pyridyl ketone (L8027) and indomethacin. Hitchcock M. Br J Pharmacol; 1980 Jun; 71(1):65-73. PubMed ID: 6162498 [Abstract] [Full Text] [Related]
23. Effects of cyclooxygenase inhibitors and prostaglandin E2 on macrophage activation in vitro. Schnyder J, Dewald B, Baggiolini M. Prostaglandins; 1981 Sep; 22(3):411-21. PubMed ID: 6795685 [Abstract] [Full Text] [Related]
24. Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile. Sok DE, Pai JK, Atrache V, Sih CJ. Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6481-5. PubMed ID: 6109281 [Abstract] [Full Text] [Related]
25. Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substance of anaphylaxis. Burka JF, Flower RJ. Br J Pharmacol; 1979 Jan; 65(1):35-41. PubMed ID: 367476 [Abstract] [Full Text] [Related]
26. Role of arachidonic acid in the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung fragments: evidence that SRS-A is very similar or identical structurally to nonimmunologically induced forms of SRS. Watanabe-Kohno S, Parker CW. J Immunol; 1980 Aug; 125(2):946-55. PubMed ID: 6104681 [No Abstract] [Full Text] [Related]
27. The effect of sodium on the biological activity of slow-reacting substances. Tsai JJ, Wang SR. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):8-14. PubMed ID: 2863094 [Abstract] [Full Text] [Related]
28. Phagocytosis-stimulated macrophages. Production of prostaglandins and SRS-A, and prostaglandin effects on macrophage activation. Baggiolini M, Schnyder J, Dewald B, Bretz U, Payne TG. Immunobiology; 1982 Apr; 161(3-4):369-75. PubMed ID: 6807833 [Abstract] [Full Text] [Related]
29. Effect of inhibitors of prostaglandin synthesis and prostaglandins E2 and F2alpha on the immunologic release of mediators of inflammation from actively sensitized guinea-pig lung. Hitchcock M. J Pharmacol Exp Ther; 1978 Nov; 207(2):630-40. PubMed ID: 712645 [Abstract] [Full Text] [Related]
30. A selective defect in arachidonic acid release from macrophage membranes in high potassium media. Aderem AA, Scott WA, Cohn ZA. J Cell Biol; 1984 Oct; 99(4 Pt 1):1235-41. PubMed ID: 6434547 [Abstract] [Full Text] [Related]
31. [Slow reacting substance from human peripheral polymorphonuclear leukocytes by incubation with fresh autologous serum and zymosan. Part 1. Requirement for SRS release from PMNs and comparison of the behavior of synthetic leukotrienes and SRS released from human PMN on HPLC]. Kishimoto M, Katagiri M, Torii S. Arerugi; 1983 Dec; 32(12):1180-5. PubMed ID: 6146300 [No Abstract] [Full Text] [Related]
32. Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway. Falkenhein SF, MacDonald H, Huber MM, Koch D, Parker CW. J Immunol; 1980 Jul; 125(1):163-8. PubMed ID: 6103910 [Abstract] [Full Text] [Related]
33. Prostaglandin biosynthesis in pulmonary macrophages. Hsueh W. Am J Pathol; 1979 Oct; 97(1):137-48. PubMed ID: 495692 [Abstract] [Full Text] [Related]
34. Comparison of arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages exposed to particulate and soluble stimuli. Bertram TA, Overby LH, Brody AR, Eling TE. Lab Invest; 1989 Oct; 61(4):457-66. PubMed ID: 2552225 [Abstract] [Full Text] [Related]
35. A possible role for lipoxygenase products as regulators of airway smooth muscle reactivity. Adcock JJ, Garland LG. Br J Pharmacol; 1980 Jun; 69(2):167-9. PubMed ID: 6777006 [Abstract] [Full Text] [Related]
36. Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. Jakschik BA, Kulczycki A, MacDonald HH, Parker CW. J Immunol; 1977 Aug; 119(2):618-22. PubMed ID: 328779 [Abstract] [Full Text] [Related]
37. Synthesis of slow-reacting substance-like activity in human anterior uvea. Kulkarni PS, Srinivasan BD. Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1201-4. PubMed ID: 3110093 [Abstract] [Full Text] [Related]
38. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. Johnston RB, Godzik CA, Cohn ZA. J Exp Med; 1978 Jul 01; 148(1):115-27. PubMed ID: 209122 [Abstract] [Full Text] [Related]
39. Relation of respiratory burst and arachidonate metabolism during phagocytosis by guinea pig alveolar macrophages. Ingraham LM, Weening RS, Clarke MF, Boxer LA, Baehner RL. J Lab Clin Med; 1982 Jun 01; 99(6):908-16. PubMed ID: 6281348 [Abstract] [Full Text] [Related]
40. Studies on the relationship between contraction and mediator release produced by ovalbumin in superfused trachea isolated from the actively sensitized guinea pig. Fishleder RI, Buckner CK. J Pharmacol Exp Ther; 1984 Sep 01; 230(3):534-40. PubMed ID: 6206223 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]